Enjoy complimentary customisation on priority with our Enterprise License!
The global HIV therapeutics market has the potential to grow by USD 2.44 billion during 2019-2023, and the market’s growth momentum will accelerate throughout the forecast period.
This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW), type (combination therapy and monotherapy), and product (reverse transcriptase inhibitors, protease inhibitors, fusion inhibitors, integrase inhibitors, and coreceptor antagonists). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors including AbbVie Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., Lupin Ltd., Merck & Co. Inc., Mylan NV, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
Browse TOC and LoE with selected illustrations and example pages from HIV therapeutics market report
Request a FREE sample now!
The market is concentrated, and the degree of concentration will decrease during the forecast period. The vendors are focusing on technological advancements in diagnostic testing and are increasingly funding the development of novel therapies. To expand their market reach, established vendors are also focusing on adopting strategic alliances. Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson & Johnson Services Inc., and Merck & Co. Inc. are some of the major market participants. Though the accelerating growth momentum will offer immense growth opportunities, the high cost of antiretroviral therapies will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this HIV therapeutics market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and provides information on the products offered by various companies. Moreover, this report also includes information on the upcoming HIV therapeutics market trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This HIV therapeutics market analysis report provides information on the production, sustainability, and prospects of several leading HIV therapeutics companies, including:
For more insights on the HIV therapeutics market share of various regions Request for a FREE sample now!
There is a growing awareness about HIV and an increase in number of initiatives to end the HIV epidemic in North America. The governments are also focusing on organizing several programs and campaigns to increase awareness and funding for HIV treatment.
Over 73% of the market’s growth will originate from North America during the forecast period. The region is witnessing the increasing prevalence of newly diagnosed cases and an increase in the diagnosis of HIV. This will subsequently drive the need for novel therapeutics, fueling HIV therapeutics market growth. The US and Canada are the key markets for HIV therapeutics in this region and market growth in North America will be faster than the growth of the market in other geographies.
Request for a FREE sample and Get more information on the market contribution of various therapeutic types
Two or more drugs from one or more drug classes are used in combination therapy for the treatment of HIV. Combination therapy has high efficiency in the treatment of HIV, and the market is witnessing the development of new combination therapies. Clinical trials on different combinations of drugs are being conducted by several vendors and researchers across the world. As the high price of combination therapy limits their preference, various government organizations are introducing reimbursement programs.
As a result, market growth in this segment will be faster than the growth of the market in the monotherapy segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the HIV therapeutics market size.
Various government organizations across the world have taken initiatives to end the HIV epidemic. These initiatives have created awareness across the globe about the advancements and discoveries of novel medicines for the treatment of HIV. Moreover, several organizations have also started supporting the public health response to global HIV epidemic. Initiatives such as Start Talking, Stop HIV, Stop HIV Stigma, and Let’s Stop HIV has increased the awareness about HIV and have helped in reducing the annual incidence of HIV infection in the US. With the growing awareness about HIV and the increasing number of initiatives to end the HIV epidemic will significantly support the growth of the HIV therapeutics market over the forecast period.
Request for a FREE sample now!
We can help! Our analysts can customize this report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: MARKET LANDSCAPE
PART 04: MARKET SIZING
PART 05: FIVE FORCES ANALYSIS
PART 06: MARKET SEGMENTATION BY TYPE
PART 07: MARKET SEGMENTATION BY PRODUCT
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
PART 14: VENDOR ANALYSIS
PART 15: APPENDIX
PART 16: EXPLORE TECHNAVIO
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.